Captor Therapeutics Spolka Akcyjna (CTX.WA)
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, develops therapeutic molecules for treating oncological and autoimmune diseases in Poland.
74.20+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+89.3%
The outlook
Captor Therapeutics Spolka Akcyjna currently reads as leaning bullish based on strong buy — 1.0 avg of 3 analysts, mixed vs its moving averages, 73% of the way from its 52-week low to high, avg target +17% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 3 analysts
Price trendMixed vs its moving averages
52-week range73% of the way from its 52-week low to high
Price targetAvg target +17% vs current price
Analyst price target
~12-month · 3 analysts86.83average target+17.0% vs now
Now 74.20
Low 67.00High 110.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$469.9M
52-wk high
89.20
52-wk low
33.00
50-day avg
76.13
200-day avg
72.61
Trailing P/E
—